This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The PTC UDI Solution Accurately Tracks All Submissions To The FDA As Well As Communications From Them (Graphic: Business Wire)

Stocks in this article: PMTC

PTC (Nasdaq: PMTC) today announced the availability of the latest release of PTC Windchill® product lifecycle management (PLM) software. PTC Windchill 10.2 adds capabilities to help manufacturers improve productivity and streamline compliance with new government regulations.

Streamline ComplianceWith FDA regulated Unique Device Identification (UDI) compliance set to take place during 2014, medical device manufacturers need a solution that will reduce the effort needed to comply with the law. The regulation specifically mandates that every unique product, product version, and product configuration be assigned a UDI to be prominently displayed on its labeling.

In requiring medical device manufacturers to provide UDI-compliant labeling, the new regulation presents them with the significant challenge of efficiently handling the vast amounts of data required for UDI-compliant submissions for each and every product, including unique product versions, variants, configurations, and packaging.

As a result, PTC has developed a preconfigured, out-of-the-box technology solution, PTC UDI, to provide for the complete management and traceability of UDI data while retaining the flexibility needed to scale to future regulatory and product development changes. This includes:

  • Collecting and Managing key UDI data from multiple data stores
  • Automating the submission process with out-of-the-box review and approval workflows and pre-submission data validation algorithms identical to those used by the FDA;
  • Streamlining the management of UDI data, both to accommodate product versions/variants and to meet the needs of future regulatory requirements from the FDA and other global agencies.

PTC Windchill 10.2 also includes many new quality related capabilities that help accelerate problem resolution. This includes tighter integration between powerful quality analyses tools and core change management processes to help improve product quality sooner – lowering the potential need for costly rework and customer issues.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs